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Polymerase chain reaction (PCR)-based open reading frame typing (POT) helps differentiate between
bacterial strains based on the open reading frames (ORFs) of the prophage-encoding genes; multiplex
PCR screening is performed to identify strains based on keeping patterns.
At our hospital, surveillance of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) trans-
mission is undertaken using POT to conduct molecular epidemiological analysis for all newly detected
MRSA strains. In 2014, we performed POT only once a month; however, in 2015, we increased the fre-
quency of POT to once a week, which helped us detect nosocomial transmission that would normally be
difﬁcult to detect, and thus achieve 40% reduction in nosocomial transmission, compared to that in 2014.
This suggests that weekly POT screening for all MRSA strains is one of the effective methods available for
minimizing nosocomial transmission of MRSA.
© 2016 The Author(s). Published by Elsevier Ltd on behalf of Japanese Society of Chemotherapy and
The Japanese Association for Infectious Diseases. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Nosocomial infections caused by various resistant bacteria have
been a source of concern in recent times. Currently, methicillin-
resistant Staphylococcus aureus (MRSA) is the most important
pathogen causing nosocomial infections. To prevent nosocomial
infection, hospitals undertake regular surveillance to detect resis-
tant bacteria, including MRSA.
At our hospital, if MRSA is isolated from newly admitted patients
within48hof admission,wedeﬁne themas “importedcases”; all other
MRSA cases are grouped under “nosocomial transmission.” However,
not all patients undergo MRSA screening upon hospitalization, and
therefore, it is very difﬁcult to accurately assess the nosocomial-ku, Osaka 545-8585, Japan.
keya).
td on behalf of Japanese Society of C
mons.org/licenses/by-nc-nd/4.0/).transmissionofMRSA.Thedrug susceptibilitypatternsofMRSAstrains
help us differentiate among isolates. However, some strains might
have identical gene patterns, but they might show different drug
susceptibility patterns; therefore, caution must be exercised when
assessing nosocomial transmission based on drug sensitivity tests
alone. Pulsed-ﬁeld gel electrophoresis (PFGE) is a highly reliable
method for assessing nosocomial transmission; however, it is time-
consuming and expensive and requires speciﬁc skills [1].
The polymerase chain reaction (PCR)-based open reading frame
typing (POT) method, developed by Suzuki et al. [2,3], is based on
phage open reading frame (ORF) typing and can differentiate
among MRSA strains. The ORFs of phage genomes lysogenized in
the MRSAs are ampliﬁed in this reaction. POT assay yields results in
only 4 h, and these results are converted into numerical values,
which allows easy comparison of previous data and data analyzed
at other facilities. Furthermore, the discriminatory power of the
POT method is reported to be equal to that of PFGE [1].hemotherapy and The Japanese Association for Infectious Diseases. This is an open access
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MRSA strains as well as the efﬁcacy of weekly analysis of all strains.2. Materials and methods
2.1. Reagents and devices
To perform POT, we used a Cica Geneus Staph POT kit (Kanto
Chemical Co., Ltd., Tokyo, Japan) and Cica Geneus DNA Extraction
Reagent (Kanto Chemical Co., Ltd.). PCR was performed using 2720
Thermal Cycler (Thermo Fisher Scientiﬁc Co., Ltd., Waltham, MA,
USA). For electrophoresis, Reliant™ Minigel TBE (Lonza Japan Co.,
Ltd., Tokyo, Japan) and Mupid-exU (Mupid Co., Ltd., Tokyo, Japan)
were used. FAS-IV (Nippon Genetics Co., Ltd., Tokyo, Japan) was
used for capturing images. Bacterial identiﬁcation and drug
susceptibility tests were performed with MicroScan WalkAway-96
SI (Beckman Coulter, Inc., Brea, CA, USA) using MicroScan Series
Panel PC1T (Beckman Coulter, Inc.).
We performed POT according to the manufacturer's instructions
to study MRSA isolates. In brief, the POT kit comprised two multi-
plex PCR reactions, and the output was determined by the presence
of 22 targets. The band size of these products was estimated with
the help of the positive control. The results are expressed as three
POT scores calculated in a binary manner [2].2.2. Frequency of POT assay to analyze MRSA strains
At our hospital, the results of microbiological tests can be
viewed in in-hospital electronic medical records; however, for
direct conﬁrmation with staff, the Infection Control Team reports
the results to the ward on the day MRSA is isolated, thereby
enabling swift contagion countermeasures.
We began using POT for genetic analysis of strains during
nosocomial MRSA outbreaks in 2010. Since 2014, however, we have
been using POT to analyze all MRSA strains detected. Furthermore,
in 2015, we increased the frequency of POT testing from once a
month to once a week.
If MRSA strains with the same POT number are detected in the
same ward, this information has to reach the medical staff in order
to draw their attention to the spread of MRSA. Moreover, such data
are reviewed weekly by the Infection Control Team, which proac-
tively intervenes if there is a possibility of an outbreak.2.3. Percentage of MRSA among S. aureus strains
To assess the effectiveness of weekly POT screening for all MRSA
strains, we compared the percentage of MRSA among S. aureus as
observed before regular testing of all strains (2013) to that with
monthly (2014) and weekly testing (2015). The formula used was
(Number of patients testing positive for MRSA/Number of patients
testing positive for S. aureus)  100.2.4. Conventional deﬁnition of MRSA outbreak and nosocomial
transmission
An MRSA outbreak has been deﬁned as three or more cases of
what is considered the same strain of MRSA within four weeks in
oneward. The deﬁnitionwas based on a notice issued by the Health
Policy Bureau, Japan's Ministry of Health, Labour and Welfare in
December 2014. MRSA nosocomial transmission has been deﬁned
as the detection of two or more cases considered to be the same
MRSA strain within six months in our hospital.2.5. Transmission rate in the same ward
To assess the effects of POT screening frequency, we compared
the transmission rate of MRSA strains in the same ward from
January to October 2014 (monthly screening) and January to
October 2015 (weekly screening). “MRSA transmission in the same
ward” has been deﬁned as two or more cases of which are
considered the same POT strain of MRSAwithin six months in same
ward.
The transmission rate was calculated using the formula (Num-
ber of cases with the same POT number in the same ward [case 2
onward]/Number of newly admitted patients with MRSA)  100.
Statistical analysis was performed using SPSS ver. 20. The yearly in-
ward transmission rates of MRSA strains were compared using chi-
square test, with P < 0.05 being considered statistically signiﬁcant.2.6. Deﬁnition of MRSA infection
We deﬁned MRSA infection as follows. Bacteremia was deﬁned
as one or more positive blood cultures from patients with clinical
signs of infection such as fever, chills, and sweats, with or without
local signs and symptoms [4]. Pneumonia was deﬁned as devel-
opment of a new pulmonary inﬁltrate based on radiographic im-
aging in conjunction with clinical signs, and MRSA was isolated
from a purulent respiratory secretion.Wound infectionwas deﬁned
as isolation of MRSA from a purulent ﬂuid drained from the wound.
Even if MRSA was isolated from various types of specimens, it was
deﬁned as “colonized” when there were no clinical signs of infec-
tion [5].3. Results
3.1. Usefulness of POT assay for molecular epidemiological analysis
of nosocomial MRSA strains
Molecular epidemiological analysis of newly isolated MRSA in
2014 and 2015 was performed using POT. The POT types of MRSA
isolates in 2014 and 2015 are listed in Tables 1a and b. The most
frequent isolate detected in 2014 was 106-137-80 (13.5%). Subse-
quently, 93-191-103 (9.1%) and 93-137-103 (5.6%) were isolated.
Similarly, the most frequent isolate detected in 2015 was 106-137-
80 (12.4%). Subsequently, 106-9-80 (4.0%) and 93-217-111 (3.6%)
were isolated. The frequencies of POT types with a unique POT
number were 35.3% and 38.2% in 2014 and 2015, respectively. We
examined the instances of nosocomial transmission of MRSA
strains isolated within 48 h of hospital admission and strains iso-
lated after >48 h of admission. In 2014, MRSA strains with the same
POT number were detected in the same ward in 76 cases, and
therefore, these were suspected to be cases of nosocomial trans-
mission. Of these 76 cases, MRSA was isolated after >48 h of
admission in 57 cases (75%), whereas it was isolated within 48 h in
19 cases (25%); the latter would thus not conventionally be
assessed as nosocomial transmission.3.2. Reduction in the rate of MRSA among all S. aureus isolates
The rate of MRSA among all S. aureus isolates was 43.8% (271/
619) in 2013, 39.5% (281/712) in 2014, and 33.5% (259/772) in 2015.
The difference between the rate in 2013 and 2014 was not statis-
tically signiﬁcant; however, the rate in 2015 was signiﬁcantly lower
than that in 2014 (Fig. 1).
Table 1a
List of POT types in 2014.
POT number Number of isolates %
106-137-80 34 13.5
93-191-103 23 9.1
93-137-103 14 5.6
93-185-124 8 3.2
93-217-56 8 3.2
106-9-80 7 2.8
93-189-125 6 2.4
93-153-125 6 2.4
93-217-111 5 2.0
93-189-111 4 1.6
93-191-125 4 1.6
106-153-115 4 1.6
93-149-109 4 1.6
93-223-111 4 1.6
93-137-2 3 1.2
93-217-107 3 1.2
93-153-127 2 0.8
106-9-34 2 0.8
93-181-109 2 0.8
108-8-16 2 0.8
93-147-109 2 0.8
70-18-81 2 0.8
93-153-56 2 0.8
93-245-109 2 0.8
93-183-101 2 0.8
93-183-37 2 0.8
106-153-120 2 0.8
93-253-125 2 0.8
98-187-88 2 0.8
Othersa 89 35.3
Total 252 100.0
a MRSA isolates with a unique POT number.
Table 1b
List of POT types in 2015.
POT number Number of isolates %
106-137-80 31 12.4
106-9-80 10 4.0
93-217-111 9 3.6
93-137-103 8 3.2
106-153-115 7 2.8
93-153-125 6 2.4
93-191-103 6 2.4
106-9-2 5 2.0
93-253-48 5 2.0
93-155-111 3 1.2
93-137-2 3 1.2
93-223-125 3 1.2
106-137-113 3 1.2
93-217-56 3 1.2
104-9-80 3 1.2
108-8-2 3 1.2
93-219-125 3 1.2
106-153-121 2 0.8
93-187-125 2 0.8
106-77-113 2 0.8
93-221-111 2 0.8
93-189-111 2 0.8
98-155-56 2 0.8
93-200-103 2 0.8
106-137-84 2 0.8
93-183-101 2 0.8
106-29-116 2 0.8
93-187-56 2 0.8
106-59-88 2 0.8
93-189-61 2 0.8
106-217-120 2 0.8
93-191-125 2 0.8
93-153-56 2 0.8
106-183-37 2 0.8
106-73-80 2 0.8
93-157-56 2 0.8
93-153-120 2 0.8
106-11-0 2 0.8
93-223-111 2 0.8
Othersa 96 38.2
Total 251 100.0
a MRSA isolates with a unique POT number.
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Fig. 1. Changes in MRSA isolation rate. MRSA detection rate: (Number of patients
testing positive for MRSA/Number of patients testing positive for S. aureus)  100 (%).
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MRSA isolates with the same POT number from the same ward
were isolated, suggesting that nosocomial transmission occurred
within the ward. In 2014, MRSA strains with the same POT number
were isolated in the sameward in 28% (70/252) cases, with 22 cases
of MRSA infection. In 2015, this percentage was 16% (40/251), with
seven cases of MRSA infection. Thus, the rate of detection of MRSA
with the same POT number in the same ward was signiﬁcantly
lower in 2015 than in 2014 (P < 0.05) (Fig. 2).
3.4. Detection of nosocomial transmission by POT screening for all
new MRSA strains
POT screening for all MRSA strains revealed a nosocomial MRSA
transmission, which could not have been detected based on the
conventional deﬁnition. Two successful cases have been described
below.
Examples of controlling infections via POT screening for all new
MRSA strains.
1) In ward A (emergency ward), MRSA was isolated from 1 to 2
patients every month; this did not meet the conventional deﬁ-
nition of an outbreak, and therefore, infection control measure
was not reinforced. However, POT screening for all new MRSA
strains showed that a single MRSA strain with the same POT
number (106-153-115) was isolated multiple times over a long
period (Fig. 3). Infection control measures for MRSA were sub-
sequently enforced, and the strain was not isolated again (data
not shown).
2) In Department B (surgical ward), MRSA was isolated from a few
patients every month until August 2013, but this did not meet
the conventional deﬁnition of an outbreak. However, POT
screening for all new MRSA strains revealed that MRSA strainswith the same POT number (106-137-80) were isolatedmultiple
times, each one case in September and November 2013, in
February and March 2014, respectively (Fig. 4a). One and three
MRSA strains with the POT number 106-137-80 were also iso-
lated in ward C (otolaryngology ward) in January to June, and in
July to December 2013, respectively (Fig. 4b). To determine the
transmission route, an environmental investigation was per-
formed in the otolaryngology outpatient ward. MRSA strains
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Fig. 2. Changes in the rate of isolation of MRSAwith the same POT number in the same ward. Black column indicates the number of MRSA strains with the same POT number in the
same ward. Gray column indicates the number of MRSA strains with different POT numbers. Detection rate of the same POT number: (Number of cases with the same POT number
in the same ward [Case 2 onward]/Number of newly admitted patients with MRSA)  100 (%).
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environment of the ward C (on the keyboard of the computer,
desk, surface of the scope). Patients carrying MRSAwith the POT
number 106-137-80 in Department B had undergone pre-
surgical otolaryngological check during hospitalization. Rein-
forcing infection control in the outpatient Department C
reduced the MRSA isolation rate in both Department B and C
(data not shown).4. Discussion
The usefulness of POT screening in controlling nosocomial in-
fections has been previously reported. In one of these studies, an
environmental investigation was performed during an MRSA
outbreak; POT screening of MRSA revealed the infection source and
route, resulting in termination of the outbreak [6]. In another study,
POT screening was introduced as a method for identifying trans-
missionwithin 48 h of hospital admission as nosocomial spread [7].
In addition, POT method considers infection factors such as places
(wards and transfer) and time (date of admission and date of
sample collection), and the number of suspected cases of nosoco-
mial transmission reduced from 118 to 38 [7]. In another study, POT
screening was reported to be useful by enabling swift intervention
via reports based on the objective data on nosocomial transmission
of MRSA [8]. Thus, POT is considered effective for controlling
nosocomial MRSA infections; however, no previous study has
assessed the efﬁcacy of routine POT analysis of all new MRSA
strains. In the present study, POT screening for all newly detected
strains of MRSA revealed the presence of identical strains that were
not detected by conventional culture and susceptibility tests. In
addition, by increasing the frequency of POT screening from once a
month to once a week, we were able to initiate infection control
earlier and reduce in-ward transmission by 40%. Furthermore,
although POT screening for all MRSA strains alone failed to help
achieve a signiﬁcant reduction over time in the percentage of MRSA
among S. aureus, a statistically signiﬁcant reduction was observed
after increasing the frequency of POT screening to once a week.
These results suggest that frequent routine POT screening is the key
to control nosocomial transmission of MRSA. Rapid reporting of
POT results to the wards and reinforcing infection control should
help reduce the nosocomial transmission of MRSA. In addition,
increased use of alcohol for hand hygiene in our hospital may have
contributed to the control of nosocomial MRSA infections. The
numbers of hand hygiene opportunities per health worker per
patient-day in our hospital were 6.6 in 2013, 10.1 in 2014, and 9.9 in
2015. The numbers soared between 2013 and 2014; however, the
number in 2015 was almost same as that in 2014. The weekly POT
was started in January 2015. Furthermore, the initiation of weekly
POT reports may have contributed to more careful environmental
cleaning and patient cohorting [9]. This may explain why the same
POT strain decreased, whereas the frequency of handwashing not
increased between 2014 and 2015 (data not shown).
In the present study, POT screening for molecular epidemio-
logical analysis of all newMRSA strains was effective for controlling
nosocomial infections. In a study by Kobayashi et al., the cost of
treatment for one patient with MRSA infectionwas estimated to be
¥4 million (~$34,000) [10]. As shown in the present study, our
measures reduced the number of cases of nosocomial MRSA
infection from 22 (2014) to 7 (2015), thereby potentially saving a
total of ¥60million (~$511,000). The cost of the POT kit and reagents
was ¥352400 in 2014 and was ¥483000 in 2015. Taking into
consideration personnel expenses, the use of weekly POT may be a
cost-effective strategy in regions or countries with a high incidence
of the nosocomial spread of MRSA.Although MRSA transmission surveillance by POT screening
could be useful, there are limitations to this approach. Because
MRSA strains with the same POT number 106-137-80 were
frequently isolated, we could not always determine the source and
route of transmission. This can be attributed to insufﬁcient inves-
tigation of the nosocomial transmission as well as failure to identify
the strains rampant in other facilities or in the community. For
more effective infection control of MRSA in the future, it is
important to share available information about the POT numbers of
MRSA among regional hospitals and facilities. These isolates might
act as endemic clones of MRSA. Therefore, we re-analyzed the rate
of detection of MRSA with the same POT number excluding the
most frequent strain (106-137-80) in the same ward. In 2014, the
percentage was 21% (46/218), with 16 cases of MRSA infection, and
in 2015, the percentage was 12% (26/209), with ﬁve cases of MRSA
infection. Thus, the rate of detection of MRSA with the same POT
number without 106-137-80 strains in the same ward was signiﬁ-
cantly lower in 2015 than in 2014 (P < 0.01). These data suggest that
the weekly POT may have contributed to the prevention of MRSA
transmission and infection in the nosocomial setting.
We conclude that weekly POT of all new isolates of MRSA may
help to identify the particular MRSA clone provoking nosocomial
transmission in an easier and timelier manner, and that rapid pe-
riodic notiﬁcation and surveillance are important for effective
control of nosocomial infections.
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